DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 1.28% to $5.52 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.33% to 18,179.98 and Dow Jones Industrial Average falling 0.61% to 41,794.60.
This was the stock's second consecutive day of gains.
Inovio Pharmaceuticals Inc. closed $9.23 below its 52-week high ($14.75), which the company achieved on April 1st.
The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.18% to $158.24, Statera Biopharma Inc. (STAB) fell 33.33% to $0.00, and Pfizer Inc. $(PFE)$ fell 1.17% to $27.76.
Trading volume (218,858) remained 73,207 below its 50-day average volume of 292,065.
Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 04, 2024 17:27 ET (22:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。